3 Momentum Stocks to Watch in Biotechnology for Continued Upside

NEW YORK (TheStreet) -- Wednesday was a strong session for a number of stocks, and here are three biotechnology plays, in particular, to watch for more upside.

Agios Pharmaceutical (AGIO) popped as high as $76.98 on Wednesday, before backing off and closing at $73.83, up 92 cents on nearly 1 million shares. It wasn't a great close, but it was a new post-initial public offering high.

With strong momentum, the stock still appears to have more upside. If the market cooperates, this stock could get up to $80 and then $88 to $90.

Natus Medical (BABY) , after a big fourth-quarter run last year, the stock consolidated for six months, popped in July, consolidated for a couple more months and recently broke out again. It has been choppy in the past few weeks, but on Wednesday it popped 55 cents to $32.80 on 865,000 shares.

That is the biggest volume since January. The stock rose as high as $33.20 intraday, a new all-time high, and, with the stock positioned near the bottom of its long-term channel, it appears to have more room to run. 

Regulus Therapeutics (RGLS) had a spectacular day Wednesday on strong Hepatitis C drug news. This stock exploded almost 200% at one point from Tuesday's close at the $6 level to as high as $18.33 on Wednesday pre-market.

It got as low as $11.13 intraday before closing at $13.75, up 6.98, or 103%, on 20 million shares. If it can get back above $15 to $15.20, this could be an $18 to $19 stock.

At the time of publication, the author held no positions in any of the stocks mentioned.

This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.

More from Opinion

Earnings Season Is Simply Out of Control Madness - How Are You Surviving?

Earnings Season Is Simply Out of Control Madness - How Are You Surviving?

Why Ether and Ripple -- But Not Bitcoin -- Prices Might Come Under Pressure Soon

Why Ether and Ripple -- But Not Bitcoin -- Prices Might Come Under Pressure Soon

Daily Chatter: Here's Where the Markets Stand After Tuesday's Beating

Daily Chatter: Here's Where the Markets Stand After Tuesday's Beating

3 New Investing Myths That Must Be Busted

3 New Investing Myths That Must Be Busted

Why a Global Stock Market Crash Is Coming

Why a Global Stock Market Crash Is Coming